Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Amphastar's Enox Back, Copaxone Ruling Next Catalyst
Tweet
Share
E-mailGet Alerts MNTA Hot Sheet
Price: $52.48 --0%
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Momenta Pharmaceuticals (NASDAQ: MNTA) price target lowered to $17.00.
Analyst, Ritu Baral, said, "Reiterating rating, reducing target to $17 on reintroduction of Amphastaar generic enox to market and lower revenues to MNTA. Yesterday’s stay on the Amphastar/WPI enox injunction returns the enox market to a multi-player, lower-economics scenario. We expect progress on biosimilars candidates as part of the new Baxter deal over 2012 and 2013. We expect the generic Copaxone suit to resolve in MNTA’s favor mid-2012."
For an analyst ratings summary and ratings history on Momenta Pharmaceuticals click here. For more ratings news on Momenta Pharmaceuticals click here.
Shares of Momenta Pharmaceuticals closed at $15.13 yesterday.
Analyst, Ritu Baral, said, "Reiterating rating, reducing target to $17 on reintroduction of Amphastaar generic enox to market and lower revenues to MNTA. Yesterday’s stay on the Amphastar/WPI enox injunction returns the enox market to a multi-player, lower-economics scenario. We expect progress on biosimilars candidates as part of the new Baxter deal over 2012 and 2013. We expect the generic Copaxone suit to resolve in MNTA’s favor mid-2012."
For an analyst ratings summary and ratings history on Momenta Pharmaceuticals click here. For more ratings news on Momenta Pharmaceuticals click here.
Shares of Momenta Pharmaceuticals closed at $15.13 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Deere (DE) PT Lowered to $728 at UBS as Agricultural Machinery Cycle Gets Closer
- Clear Street Reiterates Buy Rating on Anterix Inc. (ATEX)
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
